Aberrant Wnt/β-Catenin Signaling in Pancreatic Adenocarcinoma
Open Access
- 1 April 2006
- Vol. 8 (4) , 279-289
- https://doi.org/10.1593/neo.05607
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- β-Catenin is essential for pancreatic acinar but not islet developmentDevelopment, 2005
- The tyrosine kinase inhibitor imatinib fails to inhibit pancreatic cancer progressionCancer Letters, 2005
- Morpholino oligonucleotide-triggered β-catenin knockdown compromises normal liver regenerationJournal of Hepatology, 2005
- C–Jun–N–Terminal Kinase Drives Cyclin D1 Expression and Proliferation During Liver RegenerationHepatology, 2003
- The epidermal growth factor receptor–tyrosine kinase: A promising therapeutic target in solid tumorsSeminars in Oncology, 2003
- Selective Cyclooxygenase-2 Inhibitor Rofecoxib (Vioxx) Induces Expression of Cell Cycle Arrest Genes and Slows Tumor Growth in Human Pancreatic CancerJournal of Gastrointestinal Surgery, 2002
- The cyclooxygenase inhibitor ibuprofen and the FLAP inhibitor MK886 inhibit pancreatic carcinogenesis induced in hamsters by transplacental exposure to ethanol and the tobacco carcinogen NNKZeitschrift für Krebsforschung und Klinische Onkologie, 2002
- The Promise and Perils of Wnt Signaling Through β-CateninScience, 2002
- Genetic Aspects of Hepatocellular CarcinogenesisSeminars in Liver Disease, 1999
- WNT-1 and HGF Regulate GSK3β Activity and β-Catenin Signaling in Mammary Epithelial CellsBiochemical and Biophysical Research Communications, 1998